Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2012 Jun;3(6):594-5.
doi: 10.18632/oncotarget.549.

Destroying c-jun Messenger: new insights into biological mechanisms of DNAzyme function

Editorial

Destroying c-jun Messenger: new insights into biological mechanisms of DNAzyme function

Levon M Khachigian et al. Oncotarget. 2012 Jun.

Abstract

The study by Cai and co-workers provided novel insights into the mechanism of action of DNAzymes. Dz13 rendered c-jun mRNA unstable, reduced growth factor expression and increased apoptosis in the tumors without apparent induction of oxidative stress. Interestingly, Dz13-mediated tumor decay was more profound in immunocompetent mice syngeneic to the tumor compared with immunocompromised animals. Immunohistological inspection revealed increased immune and inflammatory cells in Dz13-treated tumors in the immunocompetent mice. In addition, Dz13 mediated tumor regression was prevented by the administration of CD4 or CD8 antibodies, which depleted the mice of the respective T cell subsets. Thus, inhibition of tumor growth by a DNAzyme involves the induction of tumor immunity. These findings suggest that c-Jun inhibition in tumors stimulates apoptosis and adaptive immune mechanisms that attack the tumor. Underpinned by a favorable preclinical safety profile, DNAzymes could provide a new treatment option combining both direct and indirect mechanisms to prevent the growth and spread of non-melanoma skin cancer.

PubMed Disclaimer

Comment on

  • DNAzyme targeting c-jun suppresses skin cancer growth.
    Cai H, Santiago FS, Prado-Lourenco L, Wang B, Patrikakis M, Davenport MP, Maghzal GJ, Stocker R, Parish CR, Chong BH, Lieschke GJ, Wong TW, Chesterman CN, Francis DJ, Moloney FJ, Barnetson RS, Halliday GM, Khachigian LM. Cai H, et al. Sci Transl Med. 2012 Jun 20;4(139):139ra82. doi: 10.1126/scitranslmed.3003960. Sci Transl Med. 2012. PMID: 22723462

References

    1. Leiter U, Garbe C. Adv Exp Med Biol. 2008;624:89–103. - PubMed
    1. Cai H, Santiago F S, Prado-Lourenco L, Patrikakis M, Wang B, Chong B H, Parish C R, Stocker R, Lieschke G, Davenport M P, Wong K T W, Chesterman C N, Francis D F, Moloney F, Barnetson R, Halliday G M, Khachigian L M. Science Translational Medicine. 2012;4:139ra182. - PubMed
    1. Zhang G, Luo X, Sumithran E, Pua V S C, Barnetson R S, Halliday G M, Khachigian L M. Oncogene. 2006;25:7260–7266. - PubMed
    1. Zhang G, Dass C R, Sumithran E, Di Girolimo N R, Sun L-Q, Khachigian L M. Journal of National Cancer Institute. 2004;96:683–696. - PubMed
    1. Santoro S W, Joyce G F. Proc. Natl. Acad. Sci. USA. 1997;94:4262–4266. - PMC - PubMed

Substances